Condensed Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Operating expense:
Research & development	$ 2,469,720	$ 986,716	$ 5,534,513	$ 2,064,562
General & administrative	4,796,155	441,959	11,890,987	892,169
Total operating expenses	7,265,875	1,428,675	17,425,500	2,956,731
Operating loss	(7,265,875)	(1,428,675)	(17,425,500)	(2,956,731)
Other (income) expense, net
Interest (income) expense, net	(125,845)		(225,213)
Total other (income) expense, net	(125,845)		(225,213)
Net Loss	$ (7,140,030)	$ (1,428,675)	$ (17,200,287)	$ (2,956,731)
Weighted Average Shares Outstanding, basic and diluted	5,843,203	2,558,419	5,701,855	2,558,419
Net loss per share, basic and diluted	$ (1.22)	$ (0.56)	$ (3.02)	$ (1.16)